CARDIA BIOPLASTICS WINS 2011 ASIA PACIFIC FROST & SULLIVAN GREEN EXCELLENCE IN TECHNOLOGY INNOVATION AWARD
The Board of Cardia Bioplastics Limited is pleased to announce that the global technology and growth consultancy, Frost & Sullivan, awarded the Cardia Bioplastics business as the recipient of their "2011 Asia Pacific Frost & Sullivan Green Excellence in Technology Innovation Award" for Eco-Materials.
Frost & Sullivan's Green Excellence Awards are presented to companies that have excelled in green product & technology innovation, and service achievements that promote sustainability.These awards recognize groundbreaking ideas and innovations that originated from a firm sense of environmental responsibility across a multitude of disciplines. Recipient companies are committed to a continuous focus on reducing their dependency on nonrenewable resources, decreasing their impact on climate change, and diminishing their overall ecological footprint.
Cardia Bioplastics Managing Director, Dr Frank Glatz, said: "The Frost & Sullivan Green Excellence in Technology Innovation Award is further international recognition of Cardia's track record and sustainable packaging offering. Cardia offers customers the choice of using sustainable Cardia BiohybridTM technology (less oil, lower carbon foot print) or Cardia's internationally certified Compostable technology for their packaging or plastic products."
Cardia Bioplastics Limited develops, manufactures and markets sustainable resins derived from renewable resources for the global packaging and plastic products industries. Cardia BiohybridTM and Compostable products deliver solutions across a range of sustainable resin technologies to offer each customer a choice of solutions for their packaging or plastics product applications. Cardia's business is benefiting from the trend towards sustainable packaging with products used in a broad range of packaging applications, including flexible film, injection moulding, blow moulding, foam, extrusion and coating applications.
About Cardia Bioplastics
Cardia Bioplastics Limited (ASX CODE: CNN), through its 100% owned subsidiary Cardia Bioplastics (Australia) Pty Ltd, develops, manufactures and markets sustainable resins and finished products derived from renewable resources for the global packaging and plastic products industries. The Company holds a strong patent portfolio and its growth are fuelled by the global trend towards sustainable packaging. Established in Australia in 2002 as Biograde, the company Headquarters and Global Applications Development Centre is in Melbourne, Australia. The Product Development Centre and manufacturing plant is in Nanjing, China. There are Cardia Bioplastics offices in the Americas, Europe, Malaysia and China, and a network of leading distributors across Australia, the Americas, Asia and Europe. Visit www.cardiabioplastics.com
Cardia Bioplastics was the exclusive supplier of biodegradable packaging to the 2008 Beijing Olympic and Paralympic Games, was awarded the Australian Chamber of Commerce "Australia-China Business Excellence Award" in 2008, and won the 2009 "Clean Equity Monaco Conference Award" for Excellence in the field of Environmental Technology Commercialisation.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents. To join our Growth Partnership, please visit awards.frost.com